J.P. Morgan analyst Julia Qin maintained a Buy rating on 10x Genomics (TXG - Research Report) on August 9 and set a price target of $65.00. The company's shares closed yesterday at $46.94.According to TipRanks, Qin is a 4-star analyst with an average return of 18.3% and a 75.00% success rate. Qin covers the Healthcare sector, focusing on stocks such as 10x Genomics, Pacific Biosciences, and NanoString Tech.Currently, the analyst consensus on 10x Genomics is a Moderate Buy with an average price target of $58.75, which is a 25.16% upside from current levels.
https://www.tipranks.com/news/blurbs/j-p-morgan-reaffirms-their-buy-rating-on-10x-genomics-txg?utm_source=advfn.com&utm_medium=referral
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Aug 2022 to Sep 2022 Click Here for more 10x Genomics Charts.
10x Genomics (NASDAQ:TXG)
Historical Stock Chart
From Sep 2021 to Sep 2022 Click Here for more 10x Genomics Charts.